Therapy With Immunoglobulin: Applications for Monoclonal Antibodies

    loading  Checking for direct PDF access through Ovid

Abstract

The ability of antibodies to recognize specific antigenic targets and trigger responses from the immune system has made them attractive candidates as therapeutic agents. Monoclonal and recombinant technology have made possible the development of a new class of therapeutic and diagnostic agents that combine the exquisite specificity of antibodies with biologic compatibility and protracted half-lives. This technology is just beginning to be explored and considerable evolution may be expected in the next few decades.

Related Topics

    loading  Loading Related Articles